These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32379395)

  • 21. Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion.
    Steensma DP; Ebert BL
    Blood; 2013 May; 121(21):4428. PubMed ID: 23704049
    [No Abstract]   [Full Text] [Related]  

  • 22. Simultaneous occurrence of the 5q- syndrome and multiple myeloma.
    Rios R; Sole F; Gascon F
    Clin Lab Haematol; 2000 Feb; 22(1):49-53. PubMed ID: 10762305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
    Jaju RJ; Jones M; Boultwood J; Kelly S; Mason DY; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 2000 Nov; 29(3):276-80. PubMed ID: 10992302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revealing the pathogenesis of the 5q- syndrome.
    Valent P
    Eur J Clin Invest; 2008 Aug; 38(8):539-40. PubMed ID: 18717823
    [No Abstract]   [Full Text] [Related]  

  • 25. Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
    Pich A; Godio L; Riera L; Cavaliere C; Kerim S; Bonello L; Francia di Celle P
    Ann Hematol; 2016 Feb; 95(3):525-7. PubMed ID: 26750119
    [No Abstract]   [Full Text] [Related]  

  • 26. Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes.
    Heise C; Carter T; Schafer P; Chopra R
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1663-72. PubMed ID: 20942636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice.
    Liu T; Ahmed T; Krysiak K; Shirai CL; Shao J; Nunley R; Bucala R; McKenzie A; Ndonwi M; Walter MJ
    Leuk Res; 2020 Sep; 96():106428. PubMed ID: 32739655
    [No Abstract]   [Full Text] [Related]  

  • 28. Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
    Savage SA; Walsh MF
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):657-668. PubMed ID: 30047418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-leucine increases translation of
    Bello E; Kerry J; Singh S; Yip BH; Kušec R; Killick S; Raynaud S; Boultwood J; Pellagatti A
    Haematologica; 2018 Nov; 103(11):e496-e500. PubMed ID: 29903759
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myelodysplastic syndrome with chromosome 5q deletion and philadelphia chromosome: case report and literatures review].
    Zhang YQ; Liu RT; Pan JQ; Xu P; Li XY; Yu LQ; Gao HY; Jiang YF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):940-942. PubMed ID: 33333699
    [No Abstract]   [Full Text] [Related]  

  • 31. [The 5q- syndrome].
    Adès L; Fenaux P
    Rev Prat; 2010 Dec; 60(10):1420-2. PubMed ID: 21425544
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).
    Cerchione C; Catalano L; Cerciello G; Avilia S; Picardi M; Risitano AM; Pisano I; Alfinito F; Pane F
    Ann Hematol; 2015 Mar; 94(3):531-4. PubMed ID: 25135452
    [No Abstract]   [Full Text] [Related]  

  • 33. Deletion 5q MDS: molecular and therapeutic implications.
    Komrokji RS; Padron E; Ebert BL; List AF
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.
    Jonasova A; Bokorova R; Polak J; Vostry M; Kostecka A; Hajkova H; Neuwirtova R; Siskova M; Sponerova D; Cermak J; Mikulenkova D; Cervinek L; Brezinova J; Michalova K; Fuchs O
    Eur J Haematol; 2015 Jul; 95(1):27-34. PubMed ID: 25284710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
    Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
    Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.
    Sanchez-Garcia J; Falantes J; Medina Perez A; Hernandez-Mohedo F; Hermosin L; Torres-Sabariego A; Bailen A; Hernandez-Sanchez JM; Solé Rodriguez M; Casaño FJ; Calderon C; Labrador M; Vahí M; Serrano J; Lumbreras E; Hernández-Rivas JM;
    Leuk Lymphoma; 2018 May; 59(5):1095-1104. PubMed ID: 28836866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 5q- syndrome: a scientific and clinical update.
    Tefferi A; Mathew P; Noël P
    Leuk Lymphoma; 1994 Aug; 14(5-6):375-8. PubMed ID: 7812195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.